Use of a lactic acid plus lactoserum intimate liquid soap for external hygiene in the prevention of bacterial vaginosis recurrence after metronidazole oral treatment;Uso do ácido láctico com lactoserum em sabonete líquido íntimo para higiene externa na prevenção da recorrência de vaginose bacteriana após tratamento oral com metronidazol

Revista da Associacao Medica Brasileira

Volumn 57, Issue 4, 2011, Pages 415-420

  Valeria Bahamondes, M ^a   Portugal, Pmscila Mendes ^a   Brolazo, Euane Melo ^a   Simões, José Antônio ^a   Bahamondes, Luis ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Bacterial vaginosis; Lactic acid; Recurrence; Treatment

Indexed keywords

EID: 80052208004     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0104-42302011000400015     Document Type: Article

References (28)

1. rd ed. New York: McGraw-Hill; 1999. p.563-86
2. th Philadelphia: Churchill Livingstone; 2000. v.2, p. 2383-6
3. Martin HL, Richardson BA, Nyange PM, Lavreys L, Hiller SL, Chohan B et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999;180:1863-8
4. Centers for Disease Control and Prevention. 1998 Guidelines for treatment of sexually transmitted diseases. MMWR Morb Mortal Wkly Rep 1998;47(RR-1):70-9
5. Livengood CH, Soper DE, Sheehan KL, Fenner DE, Martens MG, Nelson AL et al. Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosis. Sex Transm Dis 1999;26:137-42
6. Sobel JD, Schmitt C, Meriwether C. Long-term follow-up of patients with bacterial vaginosis treated with oral metronidazole and topical clindamycin. J Infect Dis 1993;167:783-4
7. Boris J, Pahlson C, Larsson PG. Six years observation after successful treatment of bacterial vaginosis. Infect Dis Obstet Gynecol 1997;5:297-302
8. Ferris DG, Francis SL, Dickman ED, Miler-Miles K, Waller JL, McClendon N. Variability of vaginal pH determination by patients and clinicians. J Am Board Fam Med 2006;19:368-73
9. Soper DE. Gynecologic complications of bacterial vaginosis: fact or fiction? Curr Infect Dis Rep 1999;1:393-7
10. Andersch B, Forssman L, Lincoln K, Torstensson P. Treatment of bacterial vaginosis with an acid cream: a comparison between the effect of lactate-gel and metronidazole. Gynecol Obstet Invest 1986;21:19-25
11. Simoes JA, Discacciati MG, Brolazo EM, Portugal PM, Dini DV, Dantas MC. Clinical diagnosis of bacterial vaginosis. Int J Gynaecol Obstet 2006;94:28-32
12. Amsel R, Totten PA, Spiegel CA, Chen KCS, Eschenbach D, Holmes KK. Non-specific vaginitis. Diagnostic criteria and microbial and epidemiological associations. Am J Med 1983;74:14-22
13. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991;29:297-301
14. Bradshaw CS, Morton AN, Hocking J, Garland SM, Morris MB, Moss LM et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 2006;193:1478-86
15. Bradshaw CS, Tabrizi SN, Fairley CK, Morton AN, Rudland E, Garland SM. The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy. J Infect Dis 2006;194:828-36
16. Gray RH, Wabwire-Mangen F, Kigozi G, Serwadda D, Moulton LH, Quinn TC et al. Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. Am J Obstet Gynecol 2001;185:1209-17
17. Camargo RP, Simões JA, Cecatti JG, Alves VM, Faro S. Impact of treatment for bacterial vaginosis on prematurity among Brazilian pregnant women: a retrospective cohort study. São Paulo Med J 2005;123:108-12
18. Hay P. Recurrent bacterial vaginosis. Curr Opin Infect Dis 2009; 22:82-6
19. Alfonsi GA, Shlay JC, Parker S, Neher JO. What is the best approach for managing recurrent bacterial vaginosis? J Fam Pract 2004;53:650-2
20. CDC Sexually Transmitted Disease Treatment Guidelines 2006. MMWR Morb Mortal Wkly Rep 2006;55:50-2
21. Clinical Effectiveness Group British Association for Sexual Health and HIV. National Guideline for the Management of Bacterial Vaginosis; 2006. [cited 2009 oct. 22. Available from:http://www.guide-line.gov
22. Sobel JD, Ferris D, Schwebke J, Nyirjesy P, Wiesenfeld HC, Peipert J et al. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol 2006;194:1283-9
23. Holley RL, Richter HE, Varner RE, Pair L, Schwebke JR. A randomized, double-blind clinical trial of vaginal acidification versus placebo for the treatment of symptomatic bacterial vaginosis. Sex Transm Dis 2004;31:236-8
24. Boeke AJ, Dekker JH, van Eijk JT, Kostense PJ, Bezemer PD. Effect of lactic acid suppositories compared with oral metronidazole and placebo in bacterial vaginosis: a randomized clinical trial. Genitourin Med 1993;69:388-92
25. Decena DCD, Co JT, Manalastas RM, Palaypayon EP, Padolina CS, Sison JM et al. Metronidazole with Lactacyd vaginal gel in bacterial vaginosis. J Obstet Gynaecol Res 2006;32:243-51
26. Ness RB, Kip KE, Soper DE, Stamm CA, Rice P, Richter HE. Variability of bacterial vaginosis over 6 to 12-month intervals. Sex Transm Dis 2006;33:381-5
27. Ferraz do Lago R, Simões JA, Bahamondes L, Camargo RP, Perrotti M, Monteiro I. Follow-up of users of intrauterine device with and without bacterial vaginosis and other cervicovaginal infections. Contraception 2003;68:105-9
28. Guaschino S, Benvenuti C; SOPHY Study Group. SOPHY project: an observational study of vaginal pH, lifestyle and correct intimate hygiene in women of different ages and in different physiopathological conditions. Part II. Minerva Ginecol 2008;60:353-62